High-Grade Squamous Intraepithelial Lesions

3

Review clinical trials related to High-Grade Squamous Intraepithelial Lesions. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

Use of ACU-D1 in HPV Associated Vulvar and Perianal Lesions in People With HIV

The goal of this study is to test the maximum tolerated dose of ACU-D1 in HIV-positive people with HPV-associated vulvar and perianal lesions. The main questions it aims to answer are: * The maximum tolerated dose of ACU-D1 * Safety and tolerability of topical ACU-D1 * Whether topical ACU-D1 induces p53 and p53-mediated downstream signaling (including p21 induction) in HPV-related lesions * Whether topical ACU-D1 enhances markers of immunity in HPV-infected HIV-positive individuals Participants will be asked * To apply ACU-D1 on the lesions twice daily for 4 weeks * 3 biopsies will be performed at the screening and 3 at the end of 4 weeks.

Participants needed: 9
Trial details
Phase: Phase 1Age: 21+Biological sex: AllType: InterventionalSponsor: Emory UniversityUpdated: May 8, 2026Locations: 1
Eligibility criteria

Age 21 years and older [+10]

Currently pregnant (confirmed by collecting urine for HCG pregnancy test) or lac...

Status: Not yet recruiting

A Multicenter Randomized Controlled Study of Photoelectric Detection in Cervical Cancer Screening

The main purpose of this study is to verify the accuracy of the fluorescence photoelectric cervical lesion image detector relative to the pathological gold standard and the detection rate of CIN 2 +, as well as the significance of it as a shunt tool before colposcopy through a randomized controlled study. The secondary objectives were to compare the relative pathological accuracy of the fluorescence photoelectric cervical lesion image detection results with the HPV detection results and cytological results, and to compare the lesion area displayed by the fluorescence photoelectric cervical lesion image detector with the lesion area that appeared after traditional colposcopy chemical staining. In this study, 4200 subjects who have been evaluated and can be enrolled (these subjects have the indication of referral to colposcopy) will be included in the study, and they will be divided into two groups according to the principle of randomization. The histological results were obtained after routine colposcopy and biopsy. The experimental group first underwent colposcopy and biopsy after the judgment of the fluorescent photoelectric cervical lesion image detector to obtain histological results. Finally, the accuracy of the relative pathological results, the detection rate of CIN2 +, negative predictive value and positive predictive value of the two groups were compared.

Participants needed: 4,200
Trial details
Age: 18-65Biological sex: FemaleType: InterventionalSponsor: Lei LiUpdated: Aug 15, 2024Locations: 1
Eligibility criteria

1. Age ≥ 18 years old, ≤ 65 years old, with a complete cervix without deformity. [+3]

1. Cannot meet all Inclusion Criteria. [+2]

Status: Not yet recruiting

A Multicenter Real-world Study of Screening of Cervical Cancer Based on Photoelectric Detection

The main purpose of this study is to explore the accuracy and clinical value of fluorescent photoelectric cervical lesion image detector as a screening and shunt tool for cervical lesions through a multi-center, large-sample real-world study with histopathology as the gold standard. The secondary purpose of the study was to verify the coincidence of the fluorescent photoelectric cervical lesion image detector with traditional colposcopic chemical staining. This study is expected to include 20,000 participants with definite histological results, and compare the specificity and sensitivity, negative predictive value and positive predictive value of three cervical lesion screening methods, such as fluorescent photoelectric cervical lesion image detector, HPV nucleic acid detection and cytology detection. The advantages and disadvantages of fluorescent photoelectric cervical disease image detector, HPV nucleic acid detection and cytology examination were analyzed, and their application scenarios were provided to provide evidence-based medical support for the establishment of comprehensive prevention and treatment system of cervical cancer suitable for China's national conditions.

Participants needed: 20,000
Trial details
Age: 18-65Biological sex: FemaleType: ObservationalSponsor: Lei LiUpdated: Jul 3, 2024Locations: 1
Eligibility criteria

1. Age ≥ 18 years old, ≤ 65 years old, with a complete cervix without deformity. [+3]

1. Cannot meet all Inclusion Criteria. [+2]